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New Regulators of Melanogenesis Are Associated with Purified 
Tyrosinase Isozymes 
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Three new regulatory factors in the melanogenesis 
pathway were recently described: dopa chrome conver-
sion factor accelerates the conversion of dopachrome to 
5,6-dihydroxyindole; indole conversion factor acceler-
ates the conversion of 5,6-dihydroxyindole into melanin; 
and indole blocking factor retards the conversion of 5,6-
dihydroxyindole into melanin. Exposure of wild-type 
Cloudman melanoma cells in culture to melanotropin 
(MSH) removes blocking factor activity and increases 
indole conversion factor activity. The chemical nature of 
the factors has not yet been determined. In this report 
we demonstrate that highly purified isozymes of tyrosin-
ase from C57Bl/6N murine hair bulbs and B16 murine 
melanoma are closely associated with conversion and 
blocking factor activities. The soluble isozymes Th T 2 , 
and Ta contain blocking · factor activity, while isozyme 
T .. , the major tyrosinase species found in melanosomes, 
contains activity that accelerates melanin formation 
from dopachrome. The results suggest that melanogen-
esis is regulated by the association of these different 
factors with the specific tyrosinase isozymes. 
In vertebrates, melanogenesis takes place in melanosomes, 
the specialized subcellular granules of pigment cells. The proc-
ess is regulated in part by melanotropin (MSH) and involves a 
complex series Qf intracellular events which are still poorly 
understood [1,2]. Melanogenesis is initiated when tyrosine is 
converted to L-3,4-dihydroxyphenylalanine (dopa) and then to 
dopaquinone by the bifunctional enzyme, tyrosinase (EC 
1.14.18.1) (Fig 1). Melanin is formed from dopaquinone in a 
series of reactions that can occur spontaneously in a test tube. 
There are at least 3, and possibly 4, isozymic forms of tyrosinase 
in mammalian melanocytes, and these isozymes have been 
purified to homogeneity by preparative polyacrylamide gel 
electrophoresis [3]. A number of characteristics of the isozymes 
have been described [4-11). Analyses of the isozymic amino 
acid composition and kinetic parameters indicate that the four 
isozymes are very similar, differing chiefly in their content of 
sialic acid and neutral sugars [12,13]' Of the 4 isozymes, only T. 
is associated with melanosomes and is actively involved in 
melanin synthesis. The other isozymes, T" T 2 and T:J, are 
thought to be precursors of T •. There is evidence that these 
precursors are synthesized on ribosomes of the rough endoplas-
mic reticulum and subsequently packaged into vesicles derivetl 
from the Goigi complex which then fuse with premelanosomes 
[14-16]. Isozyme T 2 apperu's to be an artifact of the deamidation 
of T :) during electrophoresis [13]. The TJ isozyme appears to be 
the newly synthesized molecule and the initial modification of 
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this polypeptide occurs by addition of neutral sugars (mannose 
and galactose) and sialic acid, giving rise to the TJ form [12]. 
The TJ and T:) isozymes do not appear to promote melanogen-
esis in the cell, but can be shown to convert tyrosine to dopa 
and dopa to dopaquinone in a test tube. 
Recently it was shown that reactions in the melanogenesis 
pathway distal to tyrosinase activity are under regulatory con-
trol [17,18] (Fig 1). Factors were described which accelerated: 
fIrst, the conversion of dopa chrome to 5,6-dihydroxyindole, and 
second, the conversion of 5,6-dihydl'oxyindole into melanin; a 
third agent, termed indole blocking factor, retarded melanin 
formation from 5,6-dihydroxyindole. Melanoma cells which 
were exposed to MSH had increased levels of 5,6-dihydroxyin-
dole conversion factor activity and decreased levels of indole 
blocking factor activity. Both dopachrome and 5,6-dihydl'oxyin-
dole conversion factors co-migrated with tyrosinase through 
purification with ion exchange and gel filtration procedures, 
and it was proposed that these factors might be complexed to 
tyrosinase within the pigment cell. 
We report here studies to determine whether any of the 
purified isozymes of tyrosinase are associated with regulatory 
factors which promote the conversion of dopachrome or 5,6-
dihydroxyindole into melanin. 
MATERIALS AND METHODS 
Radioactive Substrates 
L-3,5-['JH]tyrosine and L-U-C·C]tyrosine were pW'chased from the 
New England Nuclear Corporation (Boston, MA). L-3-C"C]dopa was 
purchased from Amersham Seru'le Corporation (Arlington Heights, IL). 
PW'ity of the isotope prepru'ations was determined by am ino acid 
analysis [19], and when necessary, fw·ther pW'ification was carried out 
as detailed previously [20]. L-3-["'C]dopachrome was prepru'ed from L-
3-["C]dopa as described [17]. Non-radioactive 5,6-dihydl'oxyindole was 
prepared according to Axelrod and Lerner [21]. 
Tyrosinase Isozymes 
Tyrosinase isozymes were prepru-ed from normal black mUj'ine epi-
dermis (5 day old C57B1/6N) and from B16 murine melanoma (grown 
intramuscularly in C57Bl/6N mice) as previously detailed [3,13]. 
Briefly, the 4 isozymes were isolated by gel filtration and preparative 
gel electrophoresis. T4 isozyme was recovered in the void volume of an 
LKB AcA44 Ultrogel column and used either in this partially purified 
form, or treated with trypsin (0.1 mg/ ml, pH 7.4, 37° for 30 min) to 
re lease it [Tom particulate fragments. After this treatment, the 1'" 
isozyme migrated in polyacrylamide gels at the same relative rate as 1', 
[22]. The treated isozyme is referred to in this report as "T4-trypsin." 
Tyrosin.ase Activity an.d Melan.in Syn.thesis 
The assays for tyrosinase activity and melanin synthesis were carried 
out at pH 7.4 as described previously [19,20]. Radioactivity measuj'ed 
as counts per min was converted to pmol of product formed, based on 
the specific activity of the substrates and the counting efficiency 01' the 
liquid scintillation counter. T he conversion of dopachrome and 5,6-
dihydroxyindole to melanin was measured similru·ly. Briefly, the radio-
active substrates were added to the assay system; after the noted times, 
aliquots (20 Ill) were removed to 3MM filter papers which were iJTIme- . 
diately placed in 1 liter of 0.1 N HCI and washed, to allow measurement 
of the aJTIount of radioactive, acid-insoluble melanin produced. Assays 
were carried out in duplicate and at least 3 experiments were performed 
for each point reported in the results. Background levels were estab-
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FIG 1. Stages in the oxidation of ty rosine to mela nin as modified 
from the scheme of Harley-Mason and Raper [23]. While this scheme 
depicts melanin biosynthesis as a polymerization only of indole-5,G-
quinone, it has been shown that mammalian melanins are heteropoly-
mel'S, conta ining many different combinations of the precursors shown 
[24]. For simplicity, the scheme is restricted to the eumela nin pathway, 
a nd does not include the synthesis of pheomelanin [25]. 
lished as previously detailed by the use of inhibitors, heat-treated 
enzyme, and substrate blanks for autooxidation [20]. In addition, when 
[,"C]dopachrome was prepared from ["'C]dopa, there was only a 10-
20% y ield (as determined spectrophotometrically and by a mino acid 
analysis), so appropriate blanks were subtracted for the dopa substrate 
still present in the reaction mixture. When substrate levels were in-
creased sufficiently to enable visua liza tion of the reactions, the blocking 
factor effect was overwhelmed by product formation , although t he 
effect of the conversion factor was still read ily apparent. 
RESULTS 
We prepared tyrosinase isozymes from C57Bl/6N murine 
epidermis and from B16 murine melanomas and assayed them 
using either radioactive tyrosine, dopa, or dopachl'ome as sub-
strates (Table). Under condi tio ns where a ll 4 of the isozymes 
were present in identical concentrations (with respect to their 
ability to utilize tyr osine), t he isozyme T. was about 3 times 
more effective than the other isozymes in converting dopa in to 
melanin. The reason for this increased efficiency of melanin 
formation by T" became apparent when [ '4C]dopachrome was 
used as a substrate. T" greatly accelerated the rate of conversion 
of dopachrome into melanin, while the isozymes T" T 2, and 1',1 
retarded this reaction compared to the spontaneous rate seen 
in th e blank. 
In separate experiments the kinetics of the dopachrome 
reactions over a 4 "hI' period were determined (Fig 2) . Once 
again it is evident that. the T" isozyme actually increases the 
rate of melanin formation hom labeled dopachrome, while the 
T, isozyme significantly inhibits this reaction. Equiva lent re-
sults to those shown for dopachl'ome were obtained when 5,6-
dihydroxyindole was used as a substrate (data not shown) . T hus 
we can deduce that T" contains 5,6-dihydroxyindole conversion 
factor; however, since dopachrome can convert spontaneously 
to 5,6-dihydroxyindole, OU}' experiments leave unanswered the 
question as to whether the 1'., isozyme is reacting with dopa-
chrome, or with 5,6-dihydroxyindole, when ['·C]dopachrome is 
used as the substrate. It remains to be seen, therefore, whether 
dopachrome conversion factor is also part of the T" isozyme. 
DISCUSSION 
We have recently shown that partially purified tYl'osinases 
from pigmented murine melanoma converts 5,6-dihyill'oxyin-
dole to melanin (in preparation) . We have now extended this 
work and have used pW'ified isozymes of tyrosinase to demon-
strate that, in addition to theu' previously demonstrated ability 
to convert tyrosine to dopa and dopa to dopa quinone, the T" 
T 2, and T 3 isozymes can be shown to be associated with indole 
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blocking factor activity, and the T. isozyme is associated with 
conversion factor activity. That the blocking factor activi ty is 
associated with tyrosinase isozymes T, and T3 suggests a mech-
anism by which these isozymes might be inhibited from forming 
melanin until they reach the melanosome. The association of 
indole blocking factor with tyrosinase prior to its delivery to 
the melanosome could prevent melanin and its toxic precW'sors 
from accumulating in the cytoplasm. The melanosomaJ-associ-
ated tyrosinase isozyme T", which is active in pigment synthesis 
within the melanosome, has been shown to be able to stunulate 
the conversion of 5,6-dihydroxyindole to melanin, and possibly 
may increase the rate of conversion of dopachrome to melanin 
as well. In the intracellular processing of tyrosinase, it appears 
likely that initially the de novo form of the enzyme (T~) is 
complexed with the blocking factor to inhibit premature mela-
nin formation. After glycosylation ofthe Ta isozyme to form T" 
and the delivery of this fully active (but inhibited) tyrosinase 
to the melanosome, it appears that the T, becomes part of an 
aggregate (termed T.) which consists of tyrosinase, one or more 
melanosomal membrane components, and at this tin1e the 
blocking factor is replaced by conversion factor(s). Treatment 
Action of tyrosina.se isozymes on various substrates 
Sub trate ["Hl- ["'C]- ["'C]- ["Cl-tyrosine CYTosine dopa dopaclu'ome 
Isozyme 
'1', 8.9 1.7 11.8 -G.4 
1'., 7.9 2.1 35.4 43.3 
T.-trypsin 7.8 2.] 33.4 57.5 
Resul ts ru'e reported as pmol product fonned per hour; blanks for 
autooxidation have been subtracted in each case (these were negligible 
for labeled tyrosine and dopa, a nd 26.7 pmol/hr for dopachrome). The 
negative number for 1', with dopaclU'ome substrate indicates that the 
autoox idation of dopaclu'ome in to melan in wa retarded. Essentially 
the same resul ts reported for 1', were obtained with 1'2 and T a isozymes. 
T hese data were obtained with tyrosinases prepru'ed [rom Bl6 mela-
nomas; similru' results were obta ined with isozymes isolated from nor-
ma l murine epidermis. When ["H]tyrosine was used as substrate, the 
tyrosinase assay of Pomerantz was employed. When the ["'e ]-labeled 
substrates were used, the amount of melanin formed as an acid insoluble 
precipita te was measured . 
700 
.!!! 600 
o 
E 
a.. 
z 500 
0 
~ 
::::!: 400 
a:: 
0 
u.. 
Z 300 
Z 
« 
-.J 
w 200 ::::!: 
100 
14C-Dopachrome Substrate 
x T4 Isozyme 
o H20 blank 
0 __________ - TI 
Isozyme 
-
2 3 
T IME (hrs) 
4 
FIG 2. Kinetics of the conversion of ["'C]dopachrome into melanlll 
by purified tyrosinase isozymes. T he results obtained for isozymes 1'2 
and 1'" (nol, shown) were essentia lly the same as those for 1',. Note 
that in this experiment the blank for the autooJ{idation of dopachrome 
was not subtracted. T he T.,-trypsin isozyme was s light ly more active 
than the native 1'" isozyme in convert ing dopachrome to melanin (data 
not shown). 
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of this complex with trypsin removes the membrane fragments 
from T. tyrosinase, and the T.-trypsin enzyme now again be-
haves electrophoretically identical to T ,. T hese isozymes are 
now only distinguishable by virtue of the fact that T, is asso-
ciated with blocking factor , while T4-trypsin still can be shown 
to contain conversion factor (s), in spite ofthe trypsin treatment. 
We recognize that additional experiments are necessary in order 
to prove these points unequivocaUy, and our major immediate 
goal is to elucidate the structuxes and modes of action of these 
regulatory factors. 
We thank Thomas Ekel, Paul Montague a nd Alan Bergstrom fo r 
their capable assistance. 
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Inhibition of DNA Replication and Repair by Anthralin or Danthron in 
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The comparative effects of the tumor promoter an-
thralin and its an a log, d anthron, on semiconservative 
DNA replica tion and DNA r epair synthesis w ere s tudied 
in cultured human cells . Hr omodeoxyuridine was u sed 
as den sity la bel together with "H-th ymidine to dis tin-
guish replica tion from repair synthesis in isopycnic CsCI 
gradien ts. Anthralin at 1.1 /LM inhibited r eplication in 
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T98G cells by 50%. In cells treated with 0.4 or 1.3 /LM 
a nthralin an additive effect was observed on the inhibi-
tion of replication by ultraviolet light (254 nm). In cells 
irradiated with 20 J/m2, 2.3 /LM anthralin was r equired 
to inhibit repair synthesis by 50%. Thus ther e was no 
selective inhibitory effect of anthralin on repair synthe-
sis . Danthron exhibited no de t ectable effect on either 
Sciences, Stanford University , Stanford, CA 94305. 
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Brd Urd : bromodeoxyuridine 
DMSO: dimethylsul foxide 
dThd: deoxythymidine 
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